Twenty Alzheimer's disease (AD) patients, 20 subcortical ischemic vascular dementia (SIVD) patients and 20 neurologically and cognitively normal subjects underwent transcranial magnetic stimulation to study motor cortex excitability changes. Motor threshold (MT), amplitude of motor evoked potentials, silent period and the H/M ratio (amplitude of maximal Hoffman reflex vs. that of maximal motor response) were considered. MT was lower in SIVD patients when compared with AD patients (P ¼ 0:003) and the control group (P , 0:001) and lower in AD patients when compared with the control group (P , 0:001). The increment of motor cortex excitability in AD and SIVD did not lead us to distinguish clearly the two types of dementia. It is likely that the electrophysiological similarity between AD and SIVD could represent another common mechanism shared from these forms of dementia. q 2004 Elsevier Ireland Ltd. All rights reserved.Keywords: Alzheimer's disease; Subcortical ischemic vascular dementia; Motor cortex excitability; Transcranial magnetic stimulation Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common forms of dementia, which share many pathological, symptomatic and neurochemical features [10]. Subcortical ischemic vascular dementia (SIVD) represents an important and homogeneous subtype of VaD [5]. Transcranial magnetic stimulation (TMS) is the method of choice for noninvasive stimulation of human brain in conscious subjects. It represents a valid tool to study the motor cortex excitability through the evaluation of the motor threshold (MT). In the last years, MT has been investigated in AD patients [1,15,17] but there are no reports available on motor cortex excitability in VaD patients.In the present work, motor cortex excitability changes were studied in AD and SIVD patients to assess the electrophysiological differentiation and the eventual usefulness of MT for a better clinical evaluation of these two types of dementia.Twenty SIVD patients (eight men, 12 women, age range 48-84 years, mean age 71.8^9.37 years), 20 AD patients (seven men, 13 women, age range 55-82 years, mean age 72.2^7.53 years) and 20 neurologically and cognitively intact subjects (eight men and 12 women, age range 52-80 years, mean age 68.55^7.96 years) were studied. The study was approved by the local ethics committee and informed consent was obtained from all patients (or from close relatives) and control subjects. All patients and control subjects were free of acetylcholinesterase inhibitors or other medications able to induce cortical or spinal excitability changes. The diagnosis of probable SIVD was established on a modification [5] of the NINDS-AIREN